These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 21339796

  • 1. Hepatic arterial infusion chemotherapy prior to standard systemic chemotherapy in patients with highly advanced unresectable liver metastases from colorectal cancer: a report of three patients.
    Iguchi T, Idani H, Asami S, Endo H, Inaba Y, Arai Y, Kanazawa S.
    Acta Med Okayama; 2011 Feb; 65(1):49-53. PubMed ID: 21339796
    [Abstract] [Full Text] [Related]

  • 2. Hepatic arterial infusion chemotherapy through a port-catheter system as preoperative initial therapy in patients with advanced liver dysfunction due to synchronous and unresectable liver metastases from colorectal cancer.
    Iguchi T, Arai Y, Inaba Y, Yamaura H, Sato Y, Miyazaki M, Shimamoto H.
    Cardiovasc Intervent Radiol; 2008 Feb; 31(1):86-90. PubMed ID: 17926088
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
    Guan M, Chen SC, Ying HY, Zhao L, Li XY, Zhou JF, Shao YJ, Yang XD, Lin Y, Ning XH, Bai CM.
    Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
    [Abstract] [Full Text] [Related]

  • 5. Hepatic Arterial Infusion Chemotherapy for Unresectable Liver Metastases of Colorectal Cancer: A Multicenter Retrospective Study.
    Lim A, Le Sourd S, Senellart H, Luet D, Douane F, Perret C, Bouvier A, Métairie S, Cauchin E, Rougier P, Matysiak-Budnik T, Touchefeu Y.
    Clin Colorectal Cancer; 2017 Dec; 16(4):308-315. PubMed ID: 28433600
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer.
    Kemeny N, Jarnagin W, Paty P, Gönen M, Schwartz L, Morse M, Leonard G, D'Angelica M, DeMatteo R, Blumgart L, Fong Y.
    J Clin Oncol; 2005 Aug 01; 23(22):4888-96. PubMed ID: 16009951
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer.
    Goi T, Naruse T, Kimura Y, Fujimoto D, Morikawa M, Koneri K, Yamaguchi A.
    World J Surg Oncol; 2015 Oct 09; 13():296. PubMed ID: 26452624
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Combination of hepatic arterial infusion therapy and FOLFOX for colorectal cancer with multiple unresectable liver metastases causing severe liver dysfunction].
    Suto T, Sato T, Mori N, Takano N, Ishiyama K, Sakurai N, Saito K, Iizawa H, Ikeda E.
    Gan To Kagaku Ryoho; 2009 Jan 09; 36(1):71-6. PubMed ID: 19151566
    [Abstract] [Full Text] [Related]

  • 14. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure.
    Sato Y, Inaba Y, Ura T, Nishiofuku H, Yamaura H, Kato M, Takahari D, Tanaka T, Muro K.
    J Gastrointest Cancer; 2018 Jun 09; 49(2):132-137. PubMed ID: 28058527
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Phase I/II study of radiologic hepatic arterial infusion of fluorouracil plus systemic irinotecan for unresectable hepatic metastases from colorectal cancer: Japan Clinical Oncology Group Trial 0208-DI.
    Arai Y, Ohtsu A, Sato Y, Aramaki T, Kato K, Hamada M, Muro K, Yamada Y, Inaba Y, Shimada Y, Boku N, Takeuchi Y, Morita S, Satake M.
    J Vasc Interv Radiol; 2012 Oct 09; 23(10):1261-7. PubMed ID: 22922040
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.